Newsy's Latest Health News

The Trump administration has introduced new guidelines to expedite COVID-19 vaccinations, expanding eligibility to all Americans over 65 and those with underlying conditions. The government will no longer reserve second doses, aiming to increase vaccine supply. Vaccination sites will include community health centers and pharmacies. Moderna plans to start trials for children aged 1-11, with data expected in 2022, while trials for ages 12 and up are underway. The video concludes with thanks to Kaiser Health News.

What change has the federal government made to the vaccination process?

• Vaccinations are now mandatory for all citizens.

• Vaccinations are now limited to healthcare workers only.

• Vaccinations are now open to all Americans over 65 and those with underlying conditions.

• Vaccinations are now only available in hospitals.

What is the government's new policy regarding the second dose of the vaccine?

• The second dose will be given only to healthcare workers.

• The second dose will be given only to those over 65.

• The second dose will be held back to ensure availability.

• The second dose will no longer be held back to increase supply.

Where will vaccination sites be expanded to include?

• Only rural areas

• Only private clinics

• Community health centers and more pharmacies

• Only large hospitals

When does Moderna expect to have clinical trial data for its COVID vaccine in young children?

• By the end of 2021

• In 2022

• In 2023

• By the summer of 2021

What age group is Moderna currently studying for its COVID vaccine?

• Children aged 1 to 5

• Teens aged 16 to 18

• Children and teens aged 12 and older

• Adults aged 18 and older